Clinical Research Trials Archive – Closed Trials

This is our archive of closed clinical trials, which means that they are no longer accepting new participants or have been concluded. Once a research facility has chosen to close the study, it is sorted into the GPS archive by indication. If you are interested in enrolling in a clinical trial, then please browse our list of active clinical studies.

Zip code

Condition


Search Radius:25 Miles
  • 5
  • 10
  • 15
  • 20
  • 25
  • 30
  • 40
  • 50
  • 100
  • 500
  • All

We've found
161,353
archived clinical trials in
Cancer

Phase 3 Study of ThermoDox With Radiofrequency Ablation (RFA) in Treatment of Hepatocellular Carcinoma (HCC)
A Phase III, Randomized, Double-Blinded, Dummy-Controlled Study of the Efficacy and Safety of ThermoDox® (Thermally Sensitive Liposomal Doxorubicin) in Combination With Radiofrequency Ablation (RFA) Compared to RFA-Alone in the Treatment of Non-Resectable Hepatocellular Carcinoma
Status: Enrolling
Updated:  6/7/2011
University of Texas Health Science Center
mi
from
San Antonio, TX
Phase 3 Study of ThermoDox With Radiofrequency Ablation (RFA) in Treatment of Hepatocellular Carcinoma (HCC)
A Phase III, Randomized, Double-Blinded, Dummy-Controlled Study of the Efficacy and Safety of ThermoDox® (Thermally Sensitive Liposomal Doxorubicin) in Combination With Radiofrequency Ablation (RFA) Compared to RFA-Alone in the Treatment of Non-Resectable Hepatocellular Carcinoma
Status: Enrolling
Updated: 6/7/2011
University of Texas Health Science Center
mi
from
San Antonio, TX
Click here to add this to my saved trials
Pelvic Floor Disorders in Survivors of Gynecologic Malignancies
The Prevalence and Predictive Factors of Pelvic Floor Disorders in Gynecologic Malignancy Survivors
Status: Enrolling
Updated:  6/8/2011
Abramson Cancer Center of the University of Pennsylvania
mi
from
Philadelphia, PA
Pelvic Floor Disorders in Survivors of Gynecologic Malignancies
The Prevalence and Predictive Factors of Pelvic Floor Disorders in Gynecologic Malignancy Survivors
Status: Enrolling
Updated: 6/8/2011
Abramson Cancer Center of the University of Pennsylvania
mi
from
Philadelphia, PA
Click here to add this to my saved trials
Secretin-Assisted Computed Tomography Scan and Magnetic Resonance Imaging in Improving Pancreatic Tumor Conspicuity
Evaluation of Efficiency of Secretin-Assisted Computed Tomography Scan and Secretin-Assisted Magnetic Resonance Imaging in Improving Pancreatic Enhancement and Tumor Conspicuity: Prospective Study
Status: Enrolling
Updated:  6/10/2011
University Hospitals at Case Medical Center
mi
from
Cleveland, OH
Secretin-Assisted Computed Tomography Scan and Magnetic Resonance Imaging in Improving Pancreatic Tumor Conspicuity
Evaluation of Efficiency of Secretin-Assisted Computed Tomography Scan and Secretin-Assisted Magnetic Resonance Imaging in Improving Pancreatic Enhancement and Tumor Conspicuity: Prospective Study
Status: Enrolling
Updated: 6/10/2011
University Hospitals at Case Medical Center
mi
from
Cleveland, OH
Click here to add this to my saved trials
Dose-escalation Study of Oral CX-4945
A Phase 1, Multi-Center, Open-Label, Dose-Escalation, Safety, Pharmacokinetic, and Pharmacodynamic Study of CX-4945 Administered Orally to Patients With Advanced Solid Tumors, Castleman's Disease or Multiple Myeloma
Status: Enrolling
Updated:  6/13/2011
Mayo Clinic Arizona
mi
from
Scottsdale, AZ
Dose-escalation Study of Oral CX-4945
A Phase 1, Multi-Center, Open-Label, Dose-Escalation, Safety, Pharmacokinetic, and Pharmacodynamic Study of CX-4945 Administered Orally to Patients With Advanced Solid Tumors, Castleman's Disease or Multiple Myeloma
Status: Enrolling
Updated: 6/13/2011
Mayo Clinic Arizona
mi
from
Scottsdale, AZ
Click here to add this to my saved trials
Dose-escalation Study of Oral CX-4945
A Phase 1, Multi-Center, Open-Label, Dose-Escalation, Safety, Pharmacokinetic, and Pharmacodynamic Study of CX-4945 Administered Orally to Patients With Advanced Solid Tumors, Castleman's Disease or Multiple Myeloma
Status: Enrolling
Updated:  6/13/2011
Front Range Cancer Specialists
mi
from
Fort Collins, CO
Dose-escalation Study of Oral CX-4945
A Phase 1, Multi-Center, Open-Label, Dose-Escalation, Safety, Pharmacokinetic, and Pharmacodynamic Study of CX-4945 Administered Orally to Patients With Advanced Solid Tumors, Castleman's Disease or Multiple Myeloma
Status: Enrolling
Updated: 6/13/2011
Front Range Cancer Specialists
mi
from
Fort Collins, CO
Click here to add this to my saved trials
Dose-escalation Study of Oral CX-4945
A Phase 1, Multi-Center, Open-Label, Dose-Escalation, Safety, Pharmacokinetic, and Pharmacodynamic Study of CX-4945 Administered Orally to Patients With Advanced Solid Tumors, Castleman's Disease or Multiple Myeloma
Status: Enrolling
Updated:  6/13/2011
Front Range Cancer Specialists
mi
from
Loveland, CO
Dose-escalation Study of Oral CX-4945
A Phase 1, Multi-Center, Open-Label, Dose-Escalation, Safety, Pharmacokinetic, and Pharmacodynamic Study of CX-4945 Administered Orally to Patients With Advanced Solid Tumors, Castleman's Disease or Multiple Myeloma
Status: Enrolling
Updated: 6/13/2011
Front Range Cancer Specialists
mi
from
Loveland, CO
Click here to add this to my saved trials
Dose-escalation Study of Oral CX-4945
A Phase 1, Multi-Center, Open-Label, Dose-Escalation, Safety, Pharmacokinetic, and Pharmacodynamic Study of CX-4945 Administered Orally to Patients With Advanced Solid Tumors, Castleman's Disease or Multiple Myeloma
Status: Enrolling
Updated:  6/13/2011
U T M D Anderson Cancer Center
mi
from
Houston, TX
Dose-escalation Study of Oral CX-4945
A Phase 1, Multi-Center, Open-Label, Dose-Escalation, Safety, Pharmacokinetic, and Pharmacodynamic Study of CX-4945 Administered Orally to Patients With Advanced Solid Tumors, Castleman's Disease or Multiple Myeloma
Status: Enrolling
Updated: 6/13/2011
U T M D Anderson Cancer Center
mi
from
Houston, TX
Click here to add this to my saved trials
Role of Positron Emission Mammography (PEM) Flex Solo II Positron Emission Tomography (PET) Scanner in Evaluating Neoadjuvant Chemotherapy Response in Patients With Breast Cancer
Role of PEM Flex Solo II PET Scanner in Evaluating Neoadjuvant Chemotherapy Response in Patients With Breast Cancer
Status: Enrolling
Updated:  6/14/2011
University of Chicago Medical Center
mi
from
Chicago, IL
Role of Positron Emission Mammography (PEM) Flex Solo II Positron Emission Tomography (PET) Scanner in Evaluating Neoadjuvant Chemotherapy Response in Patients With Breast Cancer
Role of PEM Flex Solo II PET Scanner in Evaluating Neoadjuvant Chemotherapy Response in Patients With Breast Cancer
Status: Enrolling
Updated: 6/14/2011
University of Chicago Medical Center
mi
from
Chicago, IL
Click here to add this to my saved trials
Celecoxib in Preventing Lung Cancer in Former Heavy Smokers
Lung Cancer Chemoprevention With Celecoxib In Ex-Smokers
Status: Enrolling
Updated:  6/16/2011
Jonsson Comprehensive Cancer Center at UCLA
mi
from
Los Angeles, CA
Celecoxib in Preventing Lung Cancer in Former Heavy Smokers
Lung Cancer Chemoprevention With Celecoxib In Ex-Smokers
Status: Enrolling
Updated: 6/16/2011
Jonsson Comprehensive Cancer Center at UCLA
mi
from
Los Angeles, CA
Click here to add this to my saved trials
Ranibizumab for Neovascularization in Sickle Cell Retinopathy
A Phase I Study to Evaluate the Ocular and Non Ocular Safety of Ranibizumab in Treating Neovascularization Secondary to Sickle Cell Retinopathy
Status: Enrolling
Updated:  6/21/2011
Kresge Eye Institute
mi
from
Detroit, MI
Ranibizumab for Neovascularization in Sickle Cell Retinopathy
A Phase I Study to Evaluate the Ocular and Non Ocular Safety of Ranibizumab in Treating Neovascularization Secondary to Sickle Cell Retinopathy
Status: Enrolling
Updated: 6/21/2011
Kresge Eye Institute
mi
from
Detroit, MI
Click here to add this to my saved trials
Use of Organic Germanium or Placebo for the Prevention of Radiation Induced Fatigue
A Phase II, Pilot, Randomized, Double-blind Study Comparing the Effectiveness Organic Germanium to Placebo in Decreasing the Severity of Fatigue in Patients Undergoing Radiation Therapy for Prostae and Bbreast Cancers
Status: Enrolling
Updated:  6/21/2011
Arizona Oncology Services
mi
from
Phoenix, AZ
Use of Organic Germanium or Placebo for the Prevention of Radiation Induced Fatigue
A Phase II, Pilot, Randomized, Double-blind Study Comparing the Effectiveness Organic Germanium to Placebo in Decreasing the Severity of Fatigue in Patients Undergoing Radiation Therapy for Prostae and Bbreast Cancers
Status: Enrolling
Updated: 6/21/2011
Arizona Oncology Services
mi
from
Phoenix, AZ
Click here to add this to my saved trials
Carboplatin as a Radiosensitizer in Treating Childhood Ependymoma
A Phase II Multi-Institutional Trial of Focal Radiotherapy With Concomitant Carboplatin as a Radiosensitizer and the Prospective Analysis of Survivin, an Inhibitor of Apoptosis, as a Biomarker in Children With Newly Diagnosed Non-Metastatic Ependymoma and Minimal Residual Disease Post-Operatively
Status: Enrolling
Updated:  6/21/2011
Ann & Robert H. Lurie Children's Hospital of Chicago
mi
from
Chicago, IL
Carboplatin as a Radiosensitizer in Treating Childhood Ependymoma
A Phase II Multi-Institutional Trial of Focal Radiotherapy With Concomitant Carboplatin as a Radiosensitizer and the Prospective Analysis of Survivin, an Inhibitor of Apoptosis, as a Biomarker in Children With Newly Diagnosed Non-Metastatic Ependymoma and Minimal Residual Disease Post-Operatively
Status: Enrolling
Updated: 6/21/2011
Ann & Robert H. Lurie Children's Hospital of Chicago
mi
from
Chicago, IL
Click here to add this to my saved trials
Hybrid Capture 2 Human Papiloma Virus (HPV) High-Risk Anal DNA Test
Collection of Anal Specimens for Assessment of Anal Cancer Using the HC2 High-Risk DNA Test (QIAGEN)
Status: Enrolling
Updated:  6/21/2011
Laser Surgery Care
mi
from
New York, NY
Hybrid Capture 2 Human Papiloma Virus (HPV) High-Risk Anal DNA Test
Collection of Anal Specimens for Assessment of Anal Cancer Using the HC2 High-Risk DNA Test (QIAGEN)
Status: Enrolling
Updated: 6/21/2011
Laser Surgery Care
mi
from
New York, NY
Click here to add this to my saved trials
Breath Test for Early Detection of Lung Cancer
Breath Test Assay for the Adjunctive Detection of Lung Cancer
Status: Enrolling
Updated:  6/23/2011
Christiana Hospital
mi
from
Newark, DE
Breath Test for Early Detection of Lung Cancer
Breath Test Assay for the Adjunctive Detection of Lung Cancer
Status: Enrolling
Updated: 6/23/2011
Christiana Hospital
mi
from
Newark, DE
Click here to add this to my saved trials
Breath Test for Early Detection of Lung Cancer
Breath Test Assay for the Adjunctive Detection of Lung Cancer
Status: Enrolling
Updated:  6/23/2011
MD Anderson Cancer Center
mi
from
Orlando, FL
Breath Test for Early Detection of Lung Cancer
Breath Test Assay for the Adjunctive Detection of Lung Cancer
Status: Enrolling
Updated: 6/23/2011
MD Anderson Cancer Center
mi
from
Orlando, FL
Click here to add this to my saved trials
Breath Test for Early Detection of Lung Cancer
Breath Test Assay for the Adjunctive Detection of Lung Cancer
Status: Enrolling
Updated:  6/23/2011
New York University Medical Center
mi
from
New York, NY
Breath Test for Early Detection of Lung Cancer
Breath Test Assay for the Adjunctive Detection of Lung Cancer
Status: Enrolling
Updated: 6/23/2011
New York University Medical Center
mi
from
New York, NY
Click here to add this to my saved trials
Breath Test for Early Detection of Lung Cancer
Breath Test Assay for the Adjunctive Detection of Lung Cancer
Status: Enrolling
Updated:  6/23/2011
Swedish Cancer Institute
mi
from
Seattle, WA
Breath Test for Early Detection of Lung Cancer
Breath Test Assay for the Adjunctive Detection of Lung Cancer
Status: Enrolling
Updated: 6/23/2011
Swedish Cancer Institute
mi
from
Seattle, WA
Click here to add this to my saved trials
Effect of Dutasteride on Androgen-Response Gene Expression in Patients With Advanced Prostate Cancer
Effect of Dutasteride on Androgen-Response Gene Expression During the Tumor Regrowth Phase of Intermittent Androgen Ablation Therapy in Patients With Advanced Prostate Cancer
Status: Enrolling
Updated:  6/24/2011
University of Chicago Hospitals and Clinics
mi
from
Chicago, IL
Effect of Dutasteride on Androgen-Response Gene Expression in Patients With Advanced Prostate Cancer
Effect of Dutasteride on Androgen-Response Gene Expression During the Tumor Regrowth Phase of Intermittent Androgen Ablation Therapy in Patients With Advanced Prostate Cancer
Status: Enrolling
Updated: 6/24/2011
University of Chicago Hospitals and Clinics
mi
from
Chicago, IL
Click here to add this to my saved trials
Effect of Dutasteride on Androgen-Response Gene Expression in Patients With Advanced Prostate Cancer
Effect of Dutasteride on Androgen-Response Gene Expression During the Tumor Regrowth Phase of Intermittent Androgen Ablation Therapy in Patients With Advanced Prostate Cancer
Status: Enrolling
Updated:  6/24/2011
Northwestern University Medical Center
mi
from
Chicago, IL
Effect of Dutasteride on Androgen-Response Gene Expression in Patients With Advanced Prostate Cancer
Effect of Dutasteride on Androgen-Response Gene Expression During the Tumor Regrowth Phase of Intermittent Androgen Ablation Therapy in Patients With Advanced Prostate Cancer
Status: Enrolling
Updated: 6/24/2011
Northwestern University Medical Center
mi
from
Chicago, IL
Click here to add this to my saved trials
Effect of Dutasteride on Androgen-Response Gene Expression in Patients With Advanced Prostate Cancer
Effect of Dutasteride on Androgen-Response Gene Expression During the Tumor Regrowth Phase of Intermittent Androgen Ablation Therapy in Patients With Advanced Prostate Cancer
Status: Enrolling
Updated:  6/24/2011
NorthShore University HealthSystem
mi
from
Evanston, IL
Effect of Dutasteride on Androgen-Response Gene Expression in Patients With Advanced Prostate Cancer
Effect of Dutasteride on Androgen-Response Gene Expression During the Tumor Regrowth Phase of Intermittent Androgen Ablation Therapy in Patients With Advanced Prostate Cancer
Status: Enrolling
Updated: 6/24/2011
NorthShore University HealthSystem
mi
from
Evanston, IL
Click here to add this to my saved trials
A Study of NK012 in Patients With Advanced, Metastatic Triple Negative Breast Cancer
A Phase II Study of NK012 in Locally Advanced Non-Resectable and Metastatic Breast Cancer Patients With Triple Negative Phenotype
Status: Enrolling
Updated:  6/24/2011
Sarah Cannon Research Institute
mi
from
Nashville, TN
A Study of NK012 in Patients With Advanced, Metastatic Triple Negative Breast Cancer
A Phase II Study of NK012 in Locally Advanced Non-Resectable and Metastatic Breast Cancer Patients With Triple Negative Phenotype
Status: Enrolling
Updated: 6/24/2011
Sarah Cannon Research Institute
mi
from
Nashville, TN
Click here to add this to my saved trials
Paclitaxel, Carboplatin and Vorinostat for the Treatment of Advanced Stage Ovarian Carcinoma
A Phase I/II, Open-Label, Non-Randomized, Pilot Study of Weekly Paclitaxel, Every Four-week Carboplatin and Oral Vorinostat for Patients Newly Diagnosed With Stage III/IV Epithelial Ovarian, Fallopian Tube or Peritoneal Cancer
Status: Enrolling
Updated:  6/24/2011
Gynecologic Oncology Associates
mi
from
Newport Beach, CA
Paclitaxel, Carboplatin and Vorinostat for the Treatment of Advanced Stage Ovarian Carcinoma
A Phase I/II, Open-Label, Non-Randomized, Pilot Study of Weekly Paclitaxel, Every Four-week Carboplatin and Oral Vorinostat for Patients Newly Diagnosed With Stage III/IV Epithelial Ovarian, Fallopian Tube or Peritoneal Cancer
Status: Enrolling
Updated: 6/24/2011
Gynecologic Oncology Associates
mi
from
Newport Beach, CA
Click here to add this to my saved trials
Study of NK012 and 5-FU/LV in Solid Tumors Followed by Dose Expansion in Colorectal Cancer
A Phase I Study of NK012 in Combination With Infusional 5-fluorouracil and Leucovorin in Patients With Advanced Solid Tumors Followed by a Dose Expansion Phase in Patients With Metastatic Colorectal Cancer
Status: Enrolling
Updated:  6/24/2011
Sarah Cannon Research Institute
mi
from
Nashville, TN
Study of NK012 and 5-FU/LV in Solid Tumors Followed by Dose Expansion in Colorectal Cancer
A Phase I Study of NK012 in Combination With Infusional 5-fluorouracil and Leucovorin in Patients With Advanced Solid Tumors Followed by a Dose Expansion Phase in Patients With Metastatic Colorectal Cancer
Status: Enrolling
Updated: 6/24/2011
Sarah Cannon Research Institute
mi
from
Nashville, TN
Click here to add this to my saved trials
Alternate Dosing Schedules Study for HPV Vaccine
Alternate Dosing Schedules Study for HPV Vaccine
Status: Enrolling
Updated:  6/28/2011
Chapel Hill Pediatrics
mi
from
Chapel Hill, NC
Alternate Dosing Schedules Study for HPV Vaccine
Alternate Dosing Schedules Study for HPV Vaccine
Status: Enrolling
Updated: 6/28/2011
Chapel Hill Pediatrics
mi
from
Chapel Hill, NC
Click here to add this to my saved trials
Alternate Dosing Schedules Study for HPV Vaccine
Alternate Dosing Schedules Study for HPV Vaccine
Status: Enrolling
Updated:  6/28/2011
Duke Children's Primary Care
mi
from
Durham, NC
Alternate Dosing Schedules Study for HPV Vaccine
Alternate Dosing Schedules Study for HPV Vaccine
Status: Enrolling
Updated: 6/28/2011
Duke Children's Primary Care
mi
from
Durham, NC
Click here to add this to my saved trials
Alternate Dosing Schedules Study for HPV Vaccine
Alternate Dosing Schedules Study for HPV Vaccine
Status: Enrolling
Updated:  6/28/2011
Durham Pediatrics
mi
from
Durham, NC
Alternate Dosing Schedules Study for HPV Vaccine
Alternate Dosing Schedules Study for HPV Vaccine
Status: Enrolling
Updated: 6/28/2011
Durham Pediatrics
mi
from
Durham, NC
Click here to add this to my saved trials
Tailored Intervention Protocol for Oral Chemotherapy Adherence
Tailored Intervention Protocol for Oral Chemotherapy Adherence
Status: Enrolling
Updated:  6/28/2011
Duke Univ Med Ctr
mi
from
Durham, NC
Tailored Intervention Protocol for Oral Chemotherapy Adherence
Tailored Intervention Protocol for Oral Chemotherapy Adherence
Status: Enrolling
Updated: 6/28/2011
Duke Univ Med Ctr
mi
from
Durham, NC
Click here to add this to my saved trials
To Evaluate the Characteristics of a Breast Cancer
Pilot Study to Characterize the HRHV Axis in the Microenvironment of Breast Cancers
Status: Enrolling
Updated:  6/28/2011
Duke Univ Med Ctr
mi
from
Durham, NC
To Evaluate the Characteristics of a Breast Cancer
Pilot Study to Characterize the HRHV Axis in the Microenvironment of Breast Cancers
Status: Enrolling
Updated: 6/28/2011
Duke Univ Med Ctr
mi
from
Durham, NC
Click here to add this to my saved trials
Fast Spectral Imaging Device for Tumor Margin Mapping
Fast Spectral Imaging Device for Tumor Margin Mapping
Status: Enrolling
Updated:  6/28/2011
Duke Univ Med Ctr
mi
from
Durham, NC
Fast Spectral Imaging Device for Tumor Margin Mapping
Fast Spectral Imaging Device for Tumor Margin Mapping
Status: Enrolling
Updated: 6/28/2011
Duke Univ Med Ctr
mi
from
Durham, NC
Click here to add this to my saved trials
Study of STA-9090, Administered Twice-Weekly in Patients With Solid Tumors
A Phase 1 Study of the HSP90 Inhibitor, STA-9090, Administered Twice-Weekly in Patients With Solid Tumors
Status: Enrolling
Updated:  7/8/2011
Dana-Farber Cancer Institute
mi
from
Boston, MA
Study of STA-9090, Administered Twice-Weekly in Patients With Solid Tumors
A Phase 1 Study of the HSP90 Inhibitor, STA-9090, Administered Twice-Weekly in Patients With Solid Tumors
Status: Enrolling
Updated: 7/8/2011
Dana-Farber Cancer Institute
mi
from
Boston, MA
Click here to add this to my saved trials
Study of STA-9090, Administered Twice-Weekly in Patients With Solid Tumors
A Phase 1 Study of the HSP90 Inhibitor, STA-9090, Administered Twice-Weekly in Patients With Solid Tumors
Status: Enrolling
Updated:  7/8/2011
Massachusetts General Hospital Cancer Center
mi
from
Boston, MA
Study of STA-9090, Administered Twice-Weekly in Patients With Solid Tumors
A Phase 1 Study of the HSP90 Inhibitor, STA-9090, Administered Twice-Weekly in Patients With Solid Tumors
Status: Enrolling
Updated: 7/8/2011
Massachusetts General Hospital Cancer Center
mi
from
Boston, MA
Click here to add this to my saved trials
Study of STA-9090, Administered Twice-Weekly in Patients With Solid Tumors
A Phase 1 Study of the HSP90 Inhibitor, STA-9090, Administered Twice-Weekly in Patients With Solid Tumors
Status: Enrolling
Updated:  7/8/2011
Beth Israel Deaconess Medical Center (BIDMC) - Cancer Center
mi
from
Boston, MA
Study of STA-9090, Administered Twice-Weekly in Patients With Solid Tumors
A Phase 1 Study of the HSP90 Inhibitor, STA-9090, Administered Twice-Weekly in Patients With Solid Tumors
Status: Enrolling
Updated: 7/8/2011
Beth Israel Deaconess Medical Center (BIDMC) - Cancer Center
mi
from
Boston, MA
Click here to add this to my saved trials
Study of STA-9090, Administered Twice-Weekly in Patients With Solid Tumors
A Phase 1 Study of the HSP90 Inhibitor, STA-9090, Administered Twice-Weekly in Patients With Solid Tumors
Status: Enrolling
Updated:  7/8/2011
Wayne State University/Karmanos Cancer Institute
mi
from
Detroit, MI
Study of STA-9090, Administered Twice-Weekly in Patients With Solid Tumors
A Phase 1 Study of the HSP90 Inhibitor, STA-9090, Administered Twice-Weekly in Patients With Solid Tumors
Status: Enrolling
Updated: 7/8/2011
Wayne State University/Karmanos Cancer Institute
mi
from
Detroit, MI
Click here to add this to my saved trials
A Dose Escalation Study of STA-9090 and Docetaxel in Patients With Solid Tumors
A Phase 1, Pharmacokinetic Study of STA-9090 in Combination With Docetaxel in Subjects With Advanced Solid Tumor Malignancies
Status: Enrolling
Updated:  7/8/2011
Emory University School of Medicine
mi
from
Atlanta, GA
A Dose Escalation Study of STA-9090 and Docetaxel in Patients With Solid Tumors
A Phase 1, Pharmacokinetic Study of STA-9090 in Combination With Docetaxel in Subjects With Advanced Solid Tumor Malignancies
Status: Enrolling
Updated: 7/8/2011
Emory University School of Medicine
mi
from
Atlanta, GA
Click here to add this to my saved trials
A Trial of Tadalafil in Patients With Squamous Cell Carcinoma of the Upper Aero Digestive Tract
A Phase II Trial of Tadalafil in Patients With Squamous Cell Carcinoma of the Upper Aero Digestive Tract
Status: Enrolling
Updated:  7/19/2011
Johns Hopkins Hospital
mi
from
Baltimore, MD
A Trial of Tadalafil in Patients With Squamous Cell Carcinoma of the Upper Aero Digestive Tract
A Phase II Trial of Tadalafil in Patients With Squamous Cell Carcinoma of the Upper Aero Digestive Tract
Status: Enrolling
Updated: 7/19/2011
Johns Hopkins Hospital
mi
from
Baltimore, MD
Click here to add this to my saved trials
Trial Comparing the Use of FLT PET to Standard CT to Assess Treatment Response of Neoadjuvant Docetaxel and Cisplatin in Stage IB-IIIA Resectable NSCLC
A Phase II Single-arm Trial Comparing the Use of FLT PET to Standard Computed Tomography to Assess Treatment Response of Neoadjuvant Docetaxel and Cisplatin in Stage IB-IIIA Resectable Non-small Lung Cancer.
Status: Enrolling
Updated:  7/19/2011
Georgetown University Hospital
mi
from
Washington,
Trial Comparing the Use of FLT PET to Standard CT to Assess Treatment Response of Neoadjuvant Docetaxel and Cisplatin in Stage IB-IIIA Resectable NSCLC
A Phase II Single-arm Trial Comparing the Use of FLT PET to Standard Computed Tomography to Assess Treatment Response of Neoadjuvant Docetaxel and Cisplatin in Stage IB-IIIA Resectable Non-small Lung Cancer.
Status: Enrolling
Updated: 7/19/2011
Georgetown University Hospital
mi
from
Washington,
Click here to add this to my saved trials
Trial Comparing the Use of FLT PET to Standard CT to Assess Treatment Response of Neoadjuvant Docetaxel and Cisplatin in Stage IB-IIIA Resectable NSCLC
A Phase II Single-arm Trial Comparing the Use of FLT PET to Standard Computed Tomography to Assess Treatment Response of Neoadjuvant Docetaxel and Cisplatin in Stage IB-IIIA Resectable Non-small Lung Cancer.
Status: Enrolling
Updated:  7/19/2011
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
mi
from
Baltimore, MD
Trial Comparing the Use of FLT PET to Standard CT to Assess Treatment Response of Neoadjuvant Docetaxel and Cisplatin in Stage IB-IIIA Resectable NSCLC
A Phase II Single-arm Trial Comparing the Use of FLT PET to Standard Computed Tomography to Assess Treatment Response of Neoadjuvant Docetaxel and Cisplatin in Stage IB-IIIA Resectable Non-small Lung Cancer.
Status: Enrolling
Updated: 7/19/2011
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
mi
from
Baltimore, MD
Click here to add this to my saved trials
Trial Comparing the Use of FLT PET to Standard CT to Assess Treatment Response of Neoadjuvant Docetaxel and Cisplatin in Stage IB-IIIA Resectable NSCLC
A Phase II Single-arm Trial Comparing the Use of FLT PET to Standard Computed Tomography to Assess Treatment Response of Neoadjuvant Docetaxel and Cisplatin in Stage IB-IIIA Resectable Non-small Lung Cancer.
Status: Enrolling
Updated:  7/19/2011
Ohio State University James Cancer Hospital and Solove Research Institute
mi
from
Columbus, OH
Trial Comparing the Use of FLT PET to Standard CT to Assess Treatment Response of Neoadjuvant Docetaxel and Cisplatin in Stage IB-IIIA Resectable NSCLC
A Phase II Single-arm Trial Comparing the Use of FLT PET to Standard Computed Tomography to Assess Treatment Response of Neoadjuvant Docetaxel and Cisplatin in Stage IB-IIIA Resectable Non-small Lung Cancer.
Status: Enrolling
Updated: 7/19/2011
Ohio State University James Cancer Hospital and Solove Research Institute
mi
from
Columbus, OH
Click here to add this to my saved trials
Endoscopic Ultrasound-guided Celiac Plexus Neurolysis in the Management of Pain in Abdominal Non-pancreatic Malignancies
Endoscopic Ultrasound (EUS)-Guided Celiac Plexus Neurolysis (CPN) in the Management of Pain in Abdominal Non-pancreatic Malignancies
Status: Enrolling
Updated:  7/19/2011
Northwestern Memorial Hospital
mi
from
Chicago, IL
Endoscopic Ultrasound-guided Celiac Plexus Neurolysis in the Management of Pain in Abdominal Non-pancreatic Malignancies
Endoscopic Ultrasound (EUS)-Guided Celiac Plexus Neurolysis (CPN) in the Management of Pain in Abdominal Non-pancreatic Malignancies
Status: Enrolling
Updated: 7/19/2011
Northwestern Memorial Hospital
mi
from
Chicago, IL
Click here to add this to my saved trials
Sorafenib to Overcome Resistance to Systemic Chemotherapy in Androgen-independent Prostate Cancer
Phase I/II Study to Evaluate the Ability of Sorafenib in Overcoming Resistance to Systemic Chemotherapy in Androgen-independent Prostate Cancer (AIPC)
Status: Enrolling
Updated:  7/20/2011
Onocology Specialists, S.C
mi
from
Niles, IL
Sorafenib to Overcome Resistance to Systemic Chemotherapy in Androgen-independent Prostate Cancer
Phase I/II Study to Evaluate the Ability of Sorafenib in Overcoming Resistance to Systemic Chemotherapy in Androgen-independent Prostate Cancer (AIPC)
Status: Enrolling
Updated: 7/20/2011
Onocology Specialists, S.C
mi
from
Niles, IL
Click here to add this to my saved trials
Sorafenib to Overcome Resistance to Systemic Chemotherapy in Androgen-independent Prostate Cancer
Phase I/II Study to Evaluate the Ability of Sorafenib in Overcoming Resistance to Systemic Chemotherapy in Androgen-independent Prostate Cancer (AIPC)
Status: Enrolling
Updated:  7/20/2011
Oncology Specialists, S.C
mi
from
Skokie, IL
Sorafenib to Overcome Resistance to Systemic Chemotherapy in Androgen-independent Prostate Cancer
Phase I/II Study to Evaluate the Ability of Sorafenib in Overcoming Resistance to Systemic Chemotherapy in Androgen-independent Prostate Cancer (AIPC)
Status: Enrolling
Updated: 7/20/2011
Oncology Specialists, S.C
mi
from
Skokie, IL
Click here to add this to my saved trials
Study Combining Imatinib Mesylate (Gleevec) With Sorafenib in Patients With Androgen-independent Prostate Cancer (AIPC)
Phase I Study Investigating the Safety and Feasibility of Combining Imatinib Mesylate (Gleevec) With Sorafenib in Patients With Androgen-Independent Chemotherapy-Failure Prostate Cancer.
Status: Enrolling
Updated:  7/20/2011
Oncology Specialists, S.C
mi
from
Skokie, IL
Study Combining Imatinib Mesylate (Gleevec) With Sorafenib in Patients With Androgen-independent Prostate Cancer (AIPC)
Phase I Study Investigating the Safety and Feasibility of Combining Imatinib Mesylate (Gleevec) With Sorafenib in Patients With Androgen-Independent Chemotherapy-Failure Prostate Cancer.
Status: Enrolling
Updated: 7/20/2011
Oncology Specialists, S.C
mi
from
Skokie, IL
Click here to add this to my saved trials
Huntsman Biopsy Study
The Huntsman Cancer Institute - The Use of Microarray Analysis in Characterizing Mesenchymal Tissue Tumors: Differentiation of Normal, Benign, and Malignant Conditions
Status: Enrolling
Updated:  7/20/2011
SUNY Upstate Medical University Hospital
mi
from
Syracuse, NY
Huntsman Biopsy Study
The Huntsman Cancer Institute - The Use of Microarray Analysis in Characterizing Mesenchymal Tissue Tumors: Differentiation of Normal, Benign, and Malignant Conditions
Status: Enrolling
Updated: 7/20/2011
SUNY Upstate Medical University Hospital
mi
from
Syracuse, NY
Click here to add this to my saved trials
Study Evaluating Toxicity & Efficacy of Lenalidomide(Revlimid®)in Chemotherapy-Naïve AIPC Patients
A Phase II Study Evaluating the Toxicity and Efficacy of Single Agent Lenalidomide (Revlimid®) in Chemotherapy-Naïve Androgen-Independent Prostate Cancer Patients
Status: Enrolling
Updated:  7/20/2011
Oncology Specialists, S.C
mi
from
Skokie, IL
Study Evaluating Toxicity & Efficacy of Lenalidomide(Revlimid®)in Chemotherapy-Naïve AIPC Patients
A Phase II Study Evaluating the Toxicity and Efficacy of Single Agent Lenalidomide (Revlimid®) in Chemotherapy-Naïve Androgen-Independent Prostate Cancer Patients
Status: Enrolling
Updated: 7/20/2011
Oncology Specialists, S.C
mi
from
Skokie, IL
Click here to add this to my saved trials
Community Volunteers Promoting Physical Activity Among Cancer Survivors
Community Volunteers Promoting Physical Activity Among Cancer Survivors
Status: Enrolling
Updated:  7/21/2011
Centers for Behavioral and Preventive Medicine, The Miriam Hospital, One Hoppin Street, Suite 314
mi
from
Providence, RI
Community Volunteers Promoting Physical Activity Among Cancer Survivors
Community Volunteers Promoting Physical Activity Among Cancer Survivors
Status: Enrolling
Updated: 7/21/2011
Centers for Behavioral and Preventive Medicine, The Miriam Hospital, One Hoppin Street, Suite 314
mi
from
Providence, RI
Click here to add this to my saved trials
Letrozole as a Treatment of Endometrial Cancer
Predicting Aromatase Inhibitor Responsiveness in Endometrial Carcinoma
Status: Enrolling
Updated:  8/4/2011
University of California-Davis
mi
from
Sacramento, CA
Letrozole as a Treatment of Endometrial Cancer
Predicting Aromatase Inhibitor Responsiveness in Endometrial Carcinoma
Status: Enrolling
Updated: 8/4/2011
University of California-Davis
mi
from
Sacramento, CA
Click here to add this to my saved trials
Letrozole as a Treatment of Endometrial Cancer
Predicting Aromatase Inhibitor Responsiveness in Endometrial Carcinoma
Status: Enrolling
Updated:  8/4/2011
University of California-Davis
mi
from
Sacramento, CA
Letrozole as a Treatment of Endometrial Cancer
Predicting Aromatase Inhibitor Responsiveness in Endometrial Carcinoma
Status: Enrolling
Updated: 8/4/2011
University of California-Davis
mi
from
Sacramento, CA
Click here to add this to my saved trials
Preoperative and Postoperative Imatinib Mesylate Study in Patients With c-Kit Positive GIST
A Prospective, Randomized, Phase II Study of Preoperative Plus Postoperative Imatinib Mesylate (Gleevec, Formerly STI-571) in Patients With Primary, Recurrent, or Metastatic Resectable, Kit-Expressing, Gastrointestinal Stromal Tumor (GIST)
Status: Enrolling
Updated:  8/4/2011
UT MD Anderson Cancer Center
mi
from
Houston, TX
Preoperative and Postoperative Imatinib Mesylate Study in Patients With c-Kit Positive GIST
A Prospective, Randomized, Phase II Study of Preoperative Plus Postoperative Imatinib Mesylate (Gleevec, Formerly STI-571) in Patients With Primary, Recurrent, or Metastatic Resectable, Kit-Expressing, Gastrointestinal Stromal Tumor (GIST)
Status: Enrolling
Updated: 8/4/2011
UT MD Anderson Cancer Center
mi
from
Houston, TX
Click here to add this to my saved trials
Heated Chemotherapy for Cancers That Have Spread to the Chest Cavity
Surgical Cytoreduction Followed by Intraoperative Intrathoracic Hyperthermic Chemotherapy Perfusion for the Management of Disseminated Pleural Malignancies
Status: Enrolling
Updated:  9/2/2011
St Luke's - Roosevelt Hospital Center
mi
from
New York, NY
Heated Chemotherapy for Cancers That Have Spread to the Chest Cavity
Surgical Cytoreduction Followed by Intraoperative Intrathoracic Hyperthermic Chemotherapy Perfusion for the Management of Disseminated Pleural Malignancies
Status: Enrolling
Updated: 9/2/2011
St Luke's - Roosevelt Hospital Center
mi
from
New York, NY
Click here to add this to my saved trials
A Pilot Study, Evaluating the Efficacy of Regulatory T-cell Suppression by Ontak in Metastatic Pancreatic Cancer
A Pilot Study Evaluating the Efficacy of Regulatory T-cell (T-reg) Suppression by Denileukin Diftitox (Ontak) in Metastatic Pancreatic Cancer
Status: Enrolling
Updated:  9/13/2011
Loyola Univeristy Medical Center, Cardinal Bernardin Cancer Center
mi
from
Maywood, IL
A Pilot Study, Evaluating the Efficacy of Regulatory T-cell Suppression by Ontak in Metastatic Pancreatic Cancer
A Pilot Study Evaluating the Efficacy of Regulatory T-cell (T-reg) Suppression by Denileukin Diftitox (Ontak) in Metastatic Pancreatic Cancer
Status: Enrolling
Updated: 9/13/2011
Loyola Univeristy Medical Center, Cardinal Bernardin Cancer Center
mi
from
Maywood, IL
Click here to add this to my saved trials